• 1
    Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108: 497505.
  • 2
    Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 1998; 21: 51824.
  • 3
    Daniel M, Rowley KG, McDermott R, Mylvaganam A, O'Dea K. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care 1999; 22: 19938.
  • 4
    Dowse GK, Zimmet PZ, Finch CF, Collins VR. Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the ‘‘thrifty genotype’’. Am J Epidemiol 1991; 133: 1093104.
  • 5
    Dowse GK. Incidence of NIDDM and the natural history of IGT in Pacific and Indian Ocean populations. Diabetes Res Clin Pract 1996; 34 (Suppl.): S4550.
  • 6
    Omar MA, Seedat MA, Dyer RB, Motala AA, Knight LT, Becker PJ. South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 1994; 17: 703.
  • 7
    Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999; 22: 2417.
  • 8
    Brissonnette LG, Fareed DS. Cardiovascular diseases as a cause of death in the island of Mauritius, 1972–1980. World Health Stat Q 1985; 38: 16375.
  • 9
    World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
  • 10
    Central Intelligence Agency (CIA). The World Factbook. Washington DC, 2003. Available from Accessed on 1 March 2004.
  • 11
    Dowse GK, Gareeboo H, Zimmet PZ et al., Mauritius Noncommunicable Disease Study Group. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes 1990; 39: 3906.
  • 12
    Dowse GK, Zimmet PZ, Gareeboo H et al. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14: 27182.
  • 13
    Dowse GK, Gareeboo H, Alberti KG et al., Mauritius Non-communicable Disease Study Group. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. BMJ 1995; 311: 12559.
  • 14
    Tuomilehto J, Dabee J, Karvonen M et al. Incidence of IDDM in Mauritian children and adolescents from 1986 to 1990. Diabetes Care 1993; 16: 158891.
  • 15
    Haffner SM, Miettinen H, Stern MP. Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 1997; 40: 626.
  • 16
    Colditz GA, Willett WC, Stampfer MJ et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 50113.
  • 17
    Eriksson KF, Lindgärde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 1996; 39: 5739.
  • 18
    Lipton RB, Liao Y, Cao G, Cooper RS, McGee D. Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1993; 138: 82639.
  • 19
    Njølstad I, Arnesen E, Lund-Larsen PG. Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study. Am J Epidemiol 1998; 147: 4958.
  • 20
    Gabir MM, Hanson RL, Dabelea D et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000; 23: 110812.
  • 21
    Edelstein SL, Knowler WC, Bain RP et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997; 46: 70110.
  • 22
    Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991; 14: 1028.
  • 23
    Hodge AM, Dowse GK, Gareeboo H, Tuomilehto J, Alberti KG, Zimmet PZ. Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord 1996; 20: 13746.
  • 24
    de Vegt F, Dekker JM, Jager A et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001; 285: 210913.
  • 25
    Alberti KG. The clinical implications of impaired glucose tolerance. Diabet Med 1996; 13: 92737.
  • 26
    Alberti KG. Impaired glucose tolerance – fact or fiction. Diabet Med 1996; 13: S68.
  • 27
    Swai AB, McLarty DG, Kitange HM et al. Study in Tanzania of impaired glucose tolerance. Methodological myth? Diabetes 1991; 40: 51620.
  • 28
    McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990; 131: 44353.
  • 29
    Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non- insulin-dependent diabetes mellitus. A prospective cohort study of men in the normative aging study. Am J Epidemiol 1992; 136: 147486.
  • 30
    Harris MI. Impaired glucose tolerance–prevalence and conversion to NIDDM. Diabet Med 1996; 13: S911.
  • 31
    Expert committee on the diagnosis and classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 118397.
  • 32
    Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 1998; 21: 11837.
  • 33
    Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E. Risk factors for NIDDM in white population. Paris prospective study. Diabetes 1991; 40: 7969.
  • 34
    Dinneen SF, Maldonado DIII, Leibson CL et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 1998; 21: 140813.
  • 35
    Ramachandran A, Snehalatha C, Naik RA, Mohan V, Shobana R, Viswanathan M. Significance of impaired glucose tolerance in an Asian Indian population: a follow-up study. Diabetes Res Clin Pract 1986; 2: 1738.
  • 36
    Motala AA, Omar MA, Gouws E. High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance. Diabetes 1993; 42: 55663.
  • 37
    Uusitalo U, Feskens EJ, Tuomilehto J et al. Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey. BMJ 1996; 313: 10446.
  • 38
    Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12: 9119.
  • 39
    Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 86370.
  • 40
    Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 134350.
  • 41
    Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 53744.
  • 42
    Shaw JE, Zimmet PZ, de Courten M et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399402.
  • 43
    Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42: 10504.